Change from baseline (%) in NFκB DNA binding by EMSA in MNC (A), TNF-α (B), IL-6 (C) mRNA expression in MNC, TNF-α plasma concentrations (D), and CRP concentrations (E) following PCE (200 mg/d) containing resveratrol (40 mg/d) or placebo treatment for 6 wk in 10 normal healthy subjects per group. *, P < 0.05 comparing changes from baseline by RMANOVA; #, P < 0.05 comparing treatments between the groups by two-way RMANOVA.